Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Indian Policy Shifts Could Force Firms To Abandon 'Second Brand' Strategies
Aug 22 2017
•
By
Anju Ghangurde
PHARMA FACES STORM CLOUDS ON THE POLICY FRONT IN INDIA
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics